The ScanWatch Rose Gold, is a health watch that monitors heart rate in a bid to reduce cardiovascular disease and combines technology and design to detect atrial fibrillation (AFib), overnight breathing disturbances, and measures oxygen saturation.
By recording the heart rate periodically, ScanWatch sends a notification when an irregular heartbeat is detected and then will advise the user to record an electrocardiogram (ECG) to detect potential atrial fibrillation.
Withings ScanWatch product manager Maxime Dumont says the watch is the world’s “most advance health wearable.”
“It scans vital parameters to detect heart health conditions and improve overall sleep and fitness. We created a solution with ScanWatch, which can be worn every day to help health monitoring and prevention much easier,” Dumont says.
ScanWatch also has the ability to track parameters such as steps, calories, elevation, workout routes, (via in app connected GPS) and can automatically recognise more than 30 daily activities such as walking, running, swimming, and cycling.
It provides fitness level assessments through an estimation of an indicator called VO2 Max, which measures the heart and muscles ability to convert oxygen into energy during physical exercise.
“Withings is here to support Aussie women and help them make better lifestyle choices over time,” Dumont continues. “Reducing stress, moving your body regularly, and making healthy lifestyle choices—quitting smoking, eating a balanced diet, and making time for exercise will contribute to good health.”
All data collected by wearing the ScanWatch is automatically synced with the free Health Mate app which provides a detailed overview of the wearer’s usage.
Health reports and ECG measurements can easily be shared with a doctor directly from the app too.
The Withings ScanWatch Rose Gold is scheduled for launch between late July and August 2021, with an RRP of A$499.